These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 25323586)

  • 1. Bcl-2 stabilization by paxillin confers 5-fluorouracil resistance in colorectal cancer.
    Wu DW; Huang CC; Chang SW; Chen TH; Lee H
    Cell Death Differ; 2015 May; 22(5):779-89. PubMed ID: 25323586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphorylation of paxillin confers cisplatin resistance in non-small cell lung cancer via activating ERK-mediated Bcl-2 expression.
    Wu DW; Wu TC; Wu JY; Cheng YW; Chen YC; Lee MC; Chen CY; Lee H
    Oncogene; 2014 Aug; 33(35):4385-95. PubMed ID: 24096476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paxillin promotes colorectal tumor invasion and poor patient outcomes via ERK-mediated stabilization of Bcl-2 protein by phosphorylation at Serine 87.
    Huang CC; Wu DW; Lin PL; Lee H
    Oncotarget; 2015 Apr; 6(11):8698-708. PubMed ID: 25826088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paxillin is positively correlated with the clinicopathological factors of colorectal cancer, and knockdown of Paxillin improves sensitivity to cetuximab in colorectal cancer cells.
    Du C; Wang X; Zhang J; Liu X; Zhu J; Liu Y
    Oncol Rep; 2016 Jan; 35(1):409-17. PubMed ID: 26530439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Regulation of paxillin tyrosine phosphorylation via inhibition of c-Abl kinase to protect ventilator induce lung injury in vivo in rats].
    Zhong R; Xiao J; Dai C; Yu Z
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2017 Jul; 29(7):596-601. PubMed ID: 28743335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paxillin confers resistance to tyrosine kinase inhibitors in EGFR-mutant lung cancers via modulating BIM and Mcl-1 protein stability.
    Wu DW; Chen CY; Chu CL; Lee H
    Oncogene; 2016 Feb; 35(5):621-30. PubMed ID: 25915848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Up-regulation of stem cell markers by P21-activated kinase 1 contributes to 5-fluorouracil resistance of colorectal cancer.
    Huynh N; Shulkes A; Baldwin G; He H
    Cancer Biol Ther; 2016 Aug; 17(8):813-23. PubMed ID: 27260988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transforming Growth Factor β Mediates Drug Resistance by Regulating the Expression of Pyruvate Dehydrogenase Kinase 4 in Colorectal Cancer.
    Zhang Y; Zhang Y; Geng L; Yi H; Huo W; Talmon G; Kim YC; Wang SM; Wang J
    J Biol Chem; 2016 Aug; 291(33):17405-16. PubMed ID: 27330076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paxillin knockdown suppresses metastasis and epithelial‑mesenchymal transition in colorectal cancer via the ERK signalling pathway.
    Wen L; Zhang X; Zhang J; Chen S; Ma Y; Hu J; Yue T; Wang J; Zhu J; Wu T; Wang X
    Oncol Rep; 2020 Sep; 44(3):1105-1115. PubMed ID: 32705241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of paxillin induced by miR-137 suppression promotes tumor progression and metastasis in colorectal cancer.
    Chen DL; Wang DS; Wu WJ; Zeng ZL; Luo HY; Qiu MZ; Ren C; Zhang DS; Wang ZQ; Wang FH; Li YH; Kang TB; Xu RH
    Carcinogenesis; 2013 Apr; 34(4):803-11. PubMed ID: 23275153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-587 antagonizes 5-FU-induced apoptosis and confers drug resistance by regulating PPP2R1B expression in colorectal cancer.
    Zhang Y; Talmon G; Wang J
    Cell Death Dis; 2015 Aug; 6(8):e1845. PubMed ID: 26247730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Paxillin Expression and Phosphorylation on Colorectal Cancer Prognosis and Metastasis.
    Zheng H; Tsunedomi R; Xu M; Zhang Y; Kishi H; Kobayashi S; Tomochika S; Nakajima M; Matsui H; Tokumitsu Y; Shindo Y; Iida M; Ioka T; Nagano H
    Anticancer Res; 2024 Feb; 44(2):511-520. PubMed ID: 38307570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Knockdown of REG Iα Enhances the Sensitivity to 5-Fluorouracil of Colorectal Cancer Cells via Cyclin D1/CDK4 Pathway and BAX/BCL-2 Pathways.
    Wang Y; Liu X; Liu J; Zhang T
    Cancer Biother Radiopharm; 2019 Aug; 34(6):362-370. PubMed ID: 30973271
    [No Abstract]   [Full Text] [Related]  

  • 14. Overexpression of hRFI inhibits 5-fluorouracil-induced apoptosis in colorectal cancer cells via activation of NF-kappaB and upregulation of BCL-2 and BCL-XL.
    Konishi T; Sasaki S; Watanabe T; Kitayama J; Nagawa H
    Oncogene; 2006 May; 25(22):3160-9. PubMed ID: 16407826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of Smad4 in colorectal cancer induces resistance to 5-fluorouracil through activating Akt pathway.
    Zhang B; Zhang B; Chen X; Bae S; Singh K; Washington MK; Datta PK
    Br J Cancer; 2014 Feb; 110(4):946-57. PubMed ID: 24384683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic induction of lipocalin 2 expression drives acquired resistance to 5-fluorouracil in colorectal cancer through integrin β3/SRC pathway.
    Zhang W; Pan R; Lu M; Zhang Q; Lin Z; Qin Y; Wang Z; Gong S; Lin H; Chong S; Lu L; Liao W; Lu X
    Oncogene; 2021 Nov; 40(45):6369-6380. PubMed ID: 34588619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TIMP-2 regulates 5-Fu resistance via the ERK/MAPK signaling pathway in colorectal cancer.
    Zhang G; Luo X; Wang Z; Xu J; Zhang W; Chen E; Meng Q; Wang D; Huang X; Zhou W; Song Z
    Aging (Albany NY); 2022 Jan; 14(1):297-315. PubMed ID: 35022331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FAK, Src and p-Paxillin expression is decreased in liver metastasis of colorectal carcinoma patients.
    Mantonakis E; Giaginis C; Pikoulis E; Felekouras E; Patsouris E; Liakakos T; Papalampros E; Theocharis S
    J BUON; 2017; 22(5):1097-1106. PubMed ID: 29135089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paxillin mutations affect focal adhesions and lead to altered mitochondrial dynamics: relevance to lung cancer.
    Kawada I; Hasina R; Lennon FE; Bindokas VP; Usatyuk P; Tan YH; Krishnaswamy S; Arif Q; Carey G; Hseu RD; Robinson M; Tretiakova M; Brand TM; Iida M; Ferguson MK; Wheeler DL; Husain AN; Natarajan V; Vokes EE; Singleton PA; Salgia R
    Cancer Biol Ther; 2013 Jul; 14(7):679-91. PubMed ID: 23792636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induced miR-31 by 5-fluorouracil exposure contributes to the resistance in colorectal tumors.
    Nakagawa Y; Kuranaga Y; Tahara T; Yamashita H; Shibata T; Nagasaka M; Funasaka K; Ohmiya N; Akao Y
    Cancer Sci; 2019 Aug; 110(8):2540-2548. PubMed ID: 31162779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.